Decoding the endometrial niche of Asherman's syndrome at single-cell resolution [organoids]

Asherman’s Syndrome is characterized by intrauterine adhesions or scarring, which cause infertility, menstrual abnormalities, and recurrent pregnancy loss. The pathophysiology of this syndrome remains unknown, with treatment restricted to recurrent surgical removal of intrauterine scarring, which has limited success. Here, we decode the Asherman’s Syndrome endometrial cell niche by analyzing data from over 200,000 cells with single-cell RNA-sequencing in patients with this condition and through in vitro analyses of Asherman’s Syndrome patient-derived endometrial organoids. Our endometrial atlas highlights the loss of the endometrial epithelium, alterations to epithelial differentiation signaling pathways such as Wnt and Notch, and the appearance of characteristic epithelium expressing secretory leukocyte protease inhibitor during the window of implantation. We describe syndrome-associated alterations in cell-to-cell communication and gene expression profiles that support a dysfunctional pro-fibrotic, pro-inflammatory, and anti-angiogenic environment. Epithelial cells derived organoids from endometrial biopsies from Asherman syndrome pre-treatment and controls **Submitter declares that the raw data will be deposited in dbGaP, as the data involves living donors under GDPR restrictions related to clinical trials (https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003975-23/ES) with signed informed consent**